SN2
SHORT NOTE
5M
★ High-yield
Classify skeletal muscle relaxants. Differentiate depolarising from non-depolarising blockers.
Definition and Classification
Skeletal muscle relaxants act at the neuromuscular junction or centrally to reduce muscle tone and produce paralysis.
| Group | Drugs | Mechanism |
|---|---|---|
| Non-depolarising (competitive) | D-tubocurarine, pancuronium, vecuronium, rocuronium, atracurium, cisatracurium, mivacurium | Competitive antagonists at the NM receptor |
| Depolarising | Succinylcholine (suxamethonium) | Persistent agonist — maintains depolarisation, so the end plate cannot repolarise and respond |
| Centrally acting | Diazepam, baclofen, tizanidine, methocarbamol | Reduce spinal reflexes |
| Directly acting | Dantrolene | Blocks calcium release from the sarcoplasmic reticulum |
Non-depolarising and Depolarising Compared
| Feature | Non-depolarising | Depolarising (succinylcholine) |
|---|---|---|
| Mechanism | Competitive antagonist | Persistent agonist |
| Initial fasciculations | Absent | Present — and cause post-operative muscle pain |
| Onset | Slower (1–3 minutes) | Very rapid (30–60 seconds) |
| Duration | Long (20–60 minutes) | Very short (5–10 minutes) |
| Effect of anticholinesterase | Reverses the block — neostigmine is the antidote | Augments and prolongs the block — must not be given |
| Effect of a small dose of a non-depolariser given first | Additive | Antagonises it — the basis of "precurarisation" to prevent fasciculation |
| Metabolism | Hepatic, renal; atracurium by spontaneous hofmann elimination, so it is safe in hepatic and renal failure | Plasma pseudocholinesterase |
| Chief use | Maintenance of relaxation during surgery | Rapid sequence intubation and brief procedures |
CLINICAL PEARL
Neostigmine reverses one block and worsens the other, which is why the distinction matters so much in practice. Raising acetylcholine helps it outcompete a competitive antagonist — so neostigmine reverses curare. But succinylcholine works by depolarising, so more acetylcholine only deepens the depolarisation. Giving neostigmine to a patient with a succinylcholine block prolongs the paralysis.
Succinylcholine — Adverse Effects
- Hyperkalaemia — depolarisation releases potassium; dangerous and sometimes fatal in burns, crush injury, denervation, prolonged immobility and spinal cord injury, where extrajunctional receptors have proliferated
- Malignant hyperthermia — a rare inherited (ryanodine receptor) reaction, usually with a volatile anaesthetic; masseter spasm, rigidity, a rapid rise in temperature, acidosis and rhabdomyolysis. Treated with dantrolene, cooling and supportive care
- Prolonged apnoea in patients with atypical pseudocholinesterase (about 1 in 3,000) or with low enzyme levels in liver disease and malnutrition; managed by continued ventilation until recovery
- Muscle pain after fasciculations; raised intraocular pressure, so it is avoided in penetrating eye injury; raised intragastric pressure; bradycardia, particularly after a second dose in children
Uses
- Endotracheal intubation — succinylcholine or rocuronium for rapid sequence induction
- Muscle relaxation during surgery, allowing lighter planes of anaesthesia and so a wider margin of safety
- Controlled ventilation in intensive care
- Electroconvulsive therapy — prevents fractures from the convulsion
- Severe tetanus and status epilepticus, with ventilation
- Spasticity — baclofen, tizanidine and diazepam centrally; dantrolene peripherally; botulinum toxin for focal spasticity
Applied Aspects
- These drugs paralyse but do not anaesthetise or relieve pain — awareness under paralysis without adequate anaesthesia is a catastrophic and well-documented complication
- Facilities for ventilation must always be available before any neuromuscular blocker is given
- Avoid succinylcholine in burns after about 24 hours, in crush injury, and in paraplegia because of hyperkalaemic cardiac arrest
- Ask about a family history of anaesthetic problems — malignant hyperthermia is inherited, and dantrolene must be stocked wherever volatile agents and succinylcholine are used
- Aminoglycosides, calcium channel blockers and hypokalaemia potentiate blockade, and can cause unexpected post-operative apnoea
- Atracurium is the relaxant of choice in hepatic and renal failure, since Hofmann elimination is independent of both organs
All questions in Autonomic Nervous System
- Q1Describe the organisation of the autonomic nervous system. Explain cholinergic and adrenergic transmission with receptor types and classify autonomic drugs. ★
- Q2Classify cholinergic drugs. Describe their pharmacological actions, uses and adverse effects. Add a note on organophosphorus poisoning. ★
- Q3Classify antimuscarinic drugs. Describe the pharmacological actions, therapeutic uses and toxicity of atropine. ★
- Q4Classify sympathomimetic drugs. Compare adrenaline, noradrenaline and isoprenaline and describe the uses of adrenaline. ★
- Q5Classify adrenergic blocking drugs. Describe the pharmacological actions, uses and adverse effects of beta-blockers. ★
- SN1Classify anticholinesterases. Differentiate neostigmine from physostigmine and describe their uses. ★
- SN2Classify skeletal muscle relaxants. Differentiate depolarising from non-depolarising blockers. ★
- SN3Classify antihypertensive drugs. Describe their adverse effects and the management of hypertensive emergency. ★
- SN4Classify the drugs used in glaucoma with their mechanisms and adverse effects. ★
- SN5Describe clonidine and methyldopa. Add a note on rebound hypertension. ★
- SN6Describe ganglion blocking drugs and explain their effects on the basis of dominant tone.
- SN7Describe the pharmacology of nicotine and the drugs used in smoking cessation. ★